Bojanić Katarina, Woodbury Jason M, Cavalcante Alexandre N, Grizelj Ruža, Asay Garth F, Colby Christopher E, Carey William A, Schears Gregory J, Weingarten Toby N, Schroeder Darrell R, Sprung Juraj
Division of Neonatology, Department of Obstetrics and Gynecology, University Hospital Merkur, Zagreb, Croatia.
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.
Paediatr Anaesth. 2017 Mar;27(3):314-321. doi: 10.1111/pan.13046. Epub 2017 Feb 17.
Congenital diaphragmatic hernia (CDH) is a rare anomaly with high mortality and long-term comorbid conditions.
Our aim was to describe the presenting characteristics, treatment, and outcomes of consecutive patients with CDH treated at our institution.
We performed a retrospective cohort study and identified consecutive neonates treated for CDH from 2001 to 2015 at our institution. For all patients identified, we reviewed hospital and postdischarge data for neonatal, disease, and treatment characteristics. We determined hospital survival overall and also according to the presence of prenatal diagnosis, liver herniation into the chest (liver up), and the use of extracorporeal membrane oxygenation (ECMO) in addition to surgery. We evaluated postdischarge chronic conditions in patients with at least one year of follow-up.
Thirty-eight neonates were admitted for treatment during the study period. In three who were in extremis, life support was withdrawn. The other 35 underwent surgical repair, of whom eight received ECMO. The overall survival was 79% (30/38). Survival for those who had surgical correction of CDH but did not need ECMO was 89% (24/27); it was 75% (6/8) for those who received ECMO and had surgery. Hospital survival was lower for liver-up vs liver-down CDH (61% [11/18] vs 95% [19/20]; odds ratio, 0.08; 95% CI, 0.01-0.77; P = 0.01). Among survivors, the median duration of hospitalization was 31 (interquartile range, 20-73) days. Major chronic pulmonary and gastrointestinal disorders, failure to thrive, and neurodevelopmental delays were the most noted comorbid conditions after discharge, and all were more prevalent in those who required ECMO.
The overall survival of neonates with CDH was 79%. Intrathoracic liver herniation was associated with more frequent use of ECMO and greater mortality. A substantial number of survivors, especially those who required ECMO, experienced chronic conditions after discharge.
先天性膈疝(CDH)是一种罕见的异常情况,死亡率高且伴有长期的合并症。
我们的目的是描述在我们机构接受治疗的连续性CDH患者的临床表现、治疗方法及预后。
我们进行了一项回顾性队列研究,确定了2001年至2015年在我们机构接受CDH治疗的连续性新生儿。对于所有确定的患者,我们回顾了医院及出院后有关新生儿、疾病和治疗特征的数据。我们确定了总体医院生存率,并根据产前诊断的存在情况、肝脏疝入胸腔(肝脏上移)以及除手术外是否使用体外膜肺氧合(ECMO)来确定生存率。我们评估了至少随访一年的患者出院后的慢性疾病情况。
在研究期间,38名新生儿入院接受治疗。其中3名病情危急,放弃了生命支持。其他35名接受了手术修复,其中8名接受了ECMO治疗。总体生存率为79%(30/38)。接受CDH手术矫正但不需要ECMO的患者生存率为89%(24/27);接受ECMO并进行手术的患者生存率为75%(6/8)。肝脏上移型CDH的医院生存率低于肝脏下移型(61% [11/18] 对95% [19/20];优势比,0.08;95%可信区间,0.01 - 0.77;P = 0.01)。在幸存者中,住院时间中位数为31(四分位间距,20 - 73)天。主要的慢性肺部和胃肠道疾病、生长发育不良以及神经发育迟缓是出院后最常见的合并症,且在需要ECMO的患者中更为普遍。
CDH新生儿的总体生存率为